US$ 20.53
new glp 1 agonist for weight loss GLP-1s Loss: What You Need to Know Treatment for Weight Loss: What
Description
The study made headlines at the 2026 American Society of Clinical Oncology (ASCO) annual meeting in June

Dual agonist: GLP-1 plus GIP: Tirzapeptide is a combination of GLP-1 RA and a GIP agonist that is FDA-approved for weight loss

These findings were further explored in the FIGHT trial, which found no reduction in rehospitalizations with liraglutide in patients recently hospitalized for HF [27]

References 1 MalikVSWilletWCHuFB
